000 01017 a2200313 4500
005 20250517192218.0
008 ####s 0 0 eng d
022 _a2055-2238
024 7 _a10.1002/osp4.133
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEngelbrechtsen, L
245 0 0 _aTreatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB.
_h[electronic resource]
260 _bObesity science & practice
_c12 2017
300 _a425-433 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aLundgren, J
700 1 _aWewer Albrechtsen, N J
700 1 _aMahendran, Y
700 1 _aIepsen, E W
700 1 _aFinocchietto, P
700 1 _aJonsson, A E
700 1 _aMadsbad, S
700 1 _aHolst, J J
700 1 _aVestergaard, H
700 1 _aHansen, T
700 1 _aTorekov, S S
773 0 _tObesity science & practice
_gvol. 3
_gno. 4
_gp. 425-433
856 4 0 _uhttps://doi.org/10.1002/osp4.133
_zAvailable from publisher's website
999 _c27907861
_d27907861